Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016, Article ID 2178218, 4 pages
http://dx.doi.org/10.1155/2016/2178218
Clinico-Pathologic Conferences

Lichtheimia ramosa: A Fatal Case of Mucormycosis

1Pulmonary Department, Hospital Álvaro Cunqueiro, EOXI Vigo, NeumoVigoI+i Research Group, Vigo Biomedical Research Institute (IBIV), Estrada Clara Campoamor No. 341, 36312 Vigo, Spain
2Critical Care Department, Hospital Álvaro Cunqueiro, EOXI Vigo, Estrada Clara Campoamor No. 341, 36312 Vigo, Spain
3Pathology Department, Hospital Álvaro Cunqueiro, EOXI Vigo, Estrada Clara Campoamor No. 341, 36312 Vigo, Spain

Received 10 June 2015; Accepted 17 November 2015

Copyright © 2016 Cecilia Mouronte-Roibás et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Mucormycosis due to Lichtheimia ramosa is an infrequent opportunistic infection that can potentially be angioinvasive when affecting inmunocompromised hosts. We present a fatal case of mucormycosis, affecting a 56-year-old male with diabetes mellitus and siderosis, initially admitted to our hospital due to an H1N1 infection. The subject’s clinical condition worsened and he finally died because of a necrotizing bilateral pneumonia with disseminated mycotic thromboses due to Lichtheimia ramosa, which is an emerging Mucoralean fungus. This is an infrequent case because of the extent to which it affected a subject without overt immunocompromise. This case underlines the importance of an early premortem diagnosis and treatment in order to prevent rapid progression of this disease, as well as the need of considering mucormycosis when facing subjects with multiple emboli and fever unresponsive to usual antimicrobials.